Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: RLS (USA) INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-10-01 to 2024-09-30
Current total value of award: $100000
Description: RADIOPHARMACEUTICAL